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I ncomplete return of normal blood flow in the reper- 
fusion period after prolonged ischemia has been 
termed the “no-reflow” phenomenon.* This has only 
recently been demonstrated in humans by intracoro- 
nary thallium-201 scintigraphy.2 In this report, we 
demonstrate the “no-reflow” phenomenon in a patient 
by digital coronary arteriography. 
A previously healthy 5a-year-old woman with 3 
hours of anginal chest pain associated with precordial 
ST-segment elevation was treated with 1.5 million U 
of intravenous streptokinase. Cardiac catheterization 
was performed 5 hours after the onset of symptoms. 
Coronary arteriography showed widely patent coro- 
nary arteries. The left ventricular ejection fraction 
was 39%, with regional akinesia in the distribution of 
the left anterior descending coronary artery (Fig. z]. 
The hospital course was unremarkable. Peak creatine 
kinase level was 849 IU. Repeat cardiac catheteriza- 
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tion was done 9 days later. The left ventricular ejec- 
tion fraction was 5a%, with apical akinesia (Fig. 1). 
Coronary arteriographic findings were again normal, 
and ergonovine (0.3 mg) provocation was negative. 
Uncertain whether the myocardial infarction was a 
FIGURE 1. Left ventriculograms in the right ant&or oblique projec- 
tions immediately after intervention (fop) and 9 days later (bofforn). 
End-diastolic (fen) and end-systolic (righf) frames are shown. Left 
ventricular function is markedly improved at the second study. 
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FIGURE 2. Contrast medium appear- 
ance pictures of the left coronary ar- 
tery in the left anterior obilque pro- 
jection acutely after intervention 
(leff) and 9 days later (righf), with a 
S.&fold increase in relative regional 
blood flow in the left anterior de- 
scending perfusion bed. 
result of coronary emboli or spasm, we empirically 
treated the patient for both with chronic aspirin, dil 
pyridamole and diltiazem therapy. 
Digital coronary arteriography of the left coronary 
artery was performed during both catheterization 
procedures.3 Contrast medium was power injected 
and synchronized to the R wave of the electrocardio- 
gram at a rate of 4 mVs for a total of 7 ml. One gated 
end-diastolic image per cardiac cycle was acquired. 
Pictures of contrast medium appearance were then 
generated by mask mode subtraction (Fig. 2). The in- 
tensity of each pixel corresponds to the maximal con- 
trast density reached during each acquisition, while 
the appearance time of contrast in the pixel is color- 
modulated, with a different color assigned to each 
post-contrast injection cardiac cycle (red for the first 
cycle, yellow for the second, and so on]. Because con- 
trast density is directly related to volume of distribu- 
tion in the myocardium and flow is inversely related 
to appearance time, digital estimation of relative coro- 
nary blood flow is calculated as the contrast den- 
sity/appearance time ratio in a defined area of inter- 
est. During the acute study, the contrast density/ap- 
pearance time ratio for the left anterior descending 
coronary artery was 6.67 and 3 days later, it was 0.25. 
This represents 3.6~fold increase in relative regional 
blood flow. 
A few minutes of ischemia disturbs the structural, 
metabolic and functional properties of reversibly in- 
jured myocardium for several days (stunned myocar- 
dium).4 The no-reflow phenomenon, however, is prob- 
ably caused by microvascular injury and does not 
occur until irreversibly injured ischemic myocardium 
is reperfused.5 In the dog, progressive loss of reper- 
fused blood flow starts to occur only after 25 minutes of 
ischemia, but is virtually complete after 60 minutes of 
ischemia.‘j Postulated mechanisms for the no-reflow 
phenomenon include endothelial cell swelling, peri- 
vascular edema, capillary plugging by erythrocytes or 
leukocytes, and small vessel spasm.3q7 
In the report by Schoffer et aL2 the acute residual 
thallium-201 defect representative of the no-reflow 
phenomenon was unchanged 2 to 4 weeks after throm- 
bolysis. The contrast medium appearance picture gen- 
erated by our digital technique, however, demon- 
strated a diffuse decrease in regional flow, which 
improved 9 days after infarction. These discordant 
findings are probably reconciled by recent data pub- 
lished by Kloner and Alker’ in a dog model. They 
describe areas of very low myocardial blood flow after 
reperfusion associated with anatomic perfusion de- 
fects, microvascular damage, and infarcted tissue con- 
sistent with no reflow. In addition, however, areas of 
low reflow detected by microspheres were present in 
the ischemic subepicardium, which did not have mi- 
crovascular damage or anatomic perfusion defects. 
They postulated that low reflow was a result of the 
lower oxygen demand of the stunned myocardium. 
The marked improvement in ventricular function 
and the low creatine kinase level in our patient suggest 
early reperfusion, a limited apical infarction, and a 
large area of stunned myocardium which recovered 
normal function. Flow data from our digital radio- 
graphic technique during reperfusion are probably 
more consistent with microsphere flow data showing 
reduced flow than with thallium-201 perfusion data, 
which reflect only lowest flow owing to myocardial 
infarction. Application of digital and scintigraphic 
techniques should allow further investigation of 
stunned myocardium and the no-reflow phenomenon 
in humans. 
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